{"id":1475,"date":"2018-07-27T05:50:11","date_gmt":"2018-07-27T04:50:11","guid":{"rendered":"http:\/\/fight-malaria-blog.local\/?p=1475"},"modified":"2020-04-02T14:17:02","modified_gmt":"2020-04-02T13:17:02","slug":"malaria-minute-friday-27th-july-2018","status":"publish","type":"post","link":"https:\/\/fight-malaria-blog.local\/malaria-minute\/malaria-minute-friday-27th-july-2018\/","title":{"rendered":"Malaria Minute | Friday 27th July 2018"},"content":{"rendered":"
The FDA’s approval of GSK’s new malaria drug Tafenoquine (Krintafel) provokes a mixed response and a research team from the ANU and The University of Queensland make a ‘small fragment of human protein’ that kills the microbial parasite that causes malaria.<\/p>\n\n